David Edward Leahy Form 8.3 - Cyprotex PLC (8360V)
21 April 2016 - 1:37AM
UK Regulatory
TIDMCRX
RNS Number : 8360V
David Edward Leahy
20 April 2016
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: David Edward leahy
---------------------------------------------------- -------------------
(b) Owner or controller of interests
and short positions disclosed,
if different from 1(a):
The naming of nominee or vehicle
companies is insufficient. For
a trust, the trustee(s), settlor
and beneficiaries must be named.
---------------------------------------------------- -------------------
(c) Name of offeror/offeree in Cyprotex PLC
relation to whose relevant securities
this form relates:
Use a separate form for each offeror/offeree
---------------------------------------------------- -------------------
(d) If an exempt fund manager connected
with an offeror/offeree, state
this and specify identity of offeror/offeree:
---------------------------------------------------- -------------------
(e) Date position held/dealing 14th April 2016
undertaken:
For an opening position disclosure,
state the latest practicable date
prior to the disclosure
---------------------------------------------------- -------------------
(f) In addition to the company N/A
in 1(c) above, is the discloser
making disclosures in respect of
any other party to the offer?
If it is a cash offer or possible
cash offer, state "N/A"
---------------------------------------------------- -------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security:
---------------------------------------- -------------------------------------
Interests Short positions
---------------------------------------- ----------------- ------------------
Number % Number %
---------------------------------------- ---------- ----- ------------- ---
(1) Relevant securities
owned and/or controlled: 1,040,160 4.63
---------------------------------------- ---------- ----- ------------- ---
(2) Cash-settled derivatives:
---------------------------------------- ---------- ----- ------------- ---
(3) Stock-settled derivatives
(including options)
and agreements to purchase/sell:
---------------------------------------- ---------- ----- ------------- ---
TOTAL: 1,040,160 4.63
---------------------------------------- ---------- ----- ------------- ---
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security 1p Ordinary
in relation to which subscription
right exists:
----------------------------------- ------------
Details, including nature
of the rights concerned and
relevant percentages:
----------------------------------- ------------
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of securities Price per unit
security
------------------ -------------- --------------------- ---------------
(b) Cash-settled derivative transactions
Class of relevant Product Nature of dealing Number of Price per
security description e.g. opening/closing reference unit
e.g. CFD a long/short position, securities
increasing/reducing
a long/short position
------------------ ------------- ------------------------ ------------ ----------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product description Writing, Number Exercise Type Expiry Option
of relevant e.g. call purchasing, of securities price e.g. American, date money
security option selling, to which per unit European paid/
varying option etc. received
etc. relates per unit
------------- -------------------- ------------- --------------- ---------- ---------------- ------- ----------
(ii) Exercise
Class of relevant Product description Exercising/ Number of Exercise price
security e.g. call exercised securities per unit
option against
------------------ -------------------- ------------ ------------ ---------------
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit
security e.g. subscription, (if applicable)
conversion
------------------ -------------------- -------- -----------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any
agreement or understanding, formal or informal, relating
to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the person making
the disclosure and any party to the offer or any person
acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not
be included. If there are no such agreements, arrangements
or understandings, state "none"
------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding,
formal or informal, between the person making the disclosure
and any other person relating to:
(i) the voting rights of any relevant securities under
any option; or
(ii) the voting rights or future acquisition or disposal
of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings,
state "none"
-------------------------------------------------------------------
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? YES/NO
---------------------------------------------------- -------
Date of disclosure: 14/04/2016
--------------------- -------------
Contact name: D E Leahy
--------------------- -------------
Telephone number: 01625 573310
--------------------- -------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market
Surveillance Unit is available for consultation in relation to the
Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETUROVRNRASUAR
(END) Dow Jones Newswires
April 20, 2016 11:37 ET (15:37 GMT)
Cyprotex (LSE:CRX)
Historical Stock Chart
From May 2024 to May 2024
Cyprotex (LSE:CRX)
Historical Stock Chart
From May 2023 to May 2024